Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global Controlled Substance Market


4. Market Overview

4.1. Introduction

4.1.1. Class Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Controlled Substance Market Analysis and Forecasts, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Market Outlook

5.1. Pipeline Analysis

5.2. Key Merger & Acquisition

5.3. Regulatory Scenario


6. Global Controlled Substance Market Analysis and Forecasts, by Drug, 2017-2027

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Drug, 2017–2027

6.3.1. Opioids

6.3.1.1. Codeine

6.3.1.2. Morphine

6.3.1.3. Fentanyl

6.3.1.4. Hydrocodone

6.3.1.5. Tramadol

6.3.1.6. Oxycodone

6.3.1.7. Others

6.3.2. Stimulants

6.3.2.1. Amphetamine

6.3.2.2. Methylphenidate

6.3.2.3. Dextroamphetamine

6.3.2.4. Methamphetamine

6.3.2.5. Modafinil

6.3.2.6. Others

6.3.3. Depressants

6.3.3.1. Barbiturates

6.3.3.2. Benzodiazepines

6.3.4. Cannabinoids

6.4. Market Attractiveness, by Drug


7. Global Controlled Substance Market Analysis and Forecasts, by Application, 2017-2027

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Application, 2017–2027

7.3.1. ADHD

7.3.2. Pain Management

7.3.3. Depression

7.3.4. Sleep Disorder

7.3.5. Cough Suppression

7.3.6. Anxiety

7.3.7. Seizure

7.3.8. Others

7.4. Market Attractiveness, by Application


8. Global Controlled Substance Market Analysis and Forecasts, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Distribution Channel, 2017–2027

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Market Attractiveness, by Application


9. Global Controlled Substance Market Analysis and Forecasts, by Region, 2017-2027

9.1. Key Findings

9.2. Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Market Attractiveness, by Region


10. North America Controlled Substance Market Analysis and Forecast, 2017-2027

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value Forecast, by Drug, 2017–2027

10.2.1. Opioids

10.2.1.1. Codeine

10.2.1.2. Morphine

10.2.1.3. Fentanyl

10.2.1.4. Hydrocodone

10.2.1.5. Tramadol

10.2.1.6. Oxycodone

10.2.1.7. Others

10.2.2. Stimulants

10.2.2.1. Amphetamine

10.2.2.2. Methylphenidate

10.2.2.3. Dextroamphetamine

10.2.2.4. Methamphetamine

10.2.2.5. Modafinil

10.2.2.6. Others

10.2.3. Depressants

10.2.3.1. Barbiturates

10.2.3.2. Benzodiazepines

10.2.4. Cannabinoids

10.3. Market Value Forecast, by Application, 2017-2027

10.3.1. ADHD

10.3.2. Pain Management

10.3.3. Depression

10.3.4. Sleep Disorder

10.3.5. Cough Suppression

10.3.6. Anxiety

10.3.7. Seizure

10.3.8. Others

10.4. Market Value Forecast, by Distribution Channel, 2017-2027

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. Market Value Forecast, by Country, 2017-2027

10.5.1. U.S.

10.5.2. Canada

10.6. Market Attractiveness Analysis

10.6.1. By Drug

10.6.2. By Application

10.6.3. By Distribution Channel

10.6.4. By Country


11. Europe Controlled Substance Market Analysis and Forecast, 2017-2027

11.1. Introduction

11.1.1. Key Finding

11.2. Market Value Forecast, by Drug, 2017-2027

11.2.1. Opioids

11.2.1.1. Codeine

11.2.1.2. Morphine

11.2.1.3. Fentanyl

11.2.1.4. Hydrocodone

11.2.1.5. Tramadol

11.2.1.6. Oxycodone

11.2.1.7. Others

11.2.2. Stimulants

11.2.2.1. Amphetamine

11.2.2.2. Methylphenidate

11.2.2.3. Dextroamphetamine

11.2.2.4. Methamphetamine

11.2.2.5. Modafinil

11.2.2.6. Others

11.2.3. Depressants

11.2.3.1. Barbiturates

11.2.3.2. Benzodiazepines

11.2.4. Cannabinoids

11.3. Market Value Forecast, by Application, 2017-2027

11.3.1. ADHD

11.3.2. Pain Management

11.3.3. Depression

11.3.4. Sleep Disorder

11.3.5. Cough Suppression

11.3.6. Anxiety

11.3.7. Seizure

11.3.8. Others

11.4. Market Value Forecast, by Distribution Channel, 2017-2027

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Online Pharmacies

11.5. Market Value Forecast, by Country/Sub-region, 2017-2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Italy

11.5.5. Spain

11.5.6. Rest of Europe

11.6. Market Attractiveness Analysis

11.6.1. By Drug

11.6.2. By Application

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region

12. Asia Pacific Controlled Substance Market Analysis and Forecast, 2017-2027

12.1. Introduction

12.1.1. Key Finding

12.2. Market Value Forecast, by Drug, 2017-2027

12.2.1. Opioids

12.2.1.1. Codeine

12.2.1.2. Morphine

12.2.1.3. Fentanyl

12.2.1.4. Hydrocodone

12.2.1.5. Tramadol

12.2.1.6. Oxycodone

12.2.1.7. Others

12.2.2. Stimulants

12.2.2.1. Amphetamine

12.2.2.2. Methylphenidate

12.2.2.3. Dextroamphetamine

12.2.2.4. Methamphetamine

12.2.2.5. Modafinil

12.2.2.6. Others

12.2.3. Depressants

12.2.3.1. Barbiturates

12.2.3.2. Benzodiazepines

12.2.4. Cannabinoids

12.3. Market Value Forecast, by Application, 2017-2027

12.3.1. ADHD

12.3.2. Pain Management

12.3.3. Depression

12.3.4. Sleep Disorder

12.3.5. Cough Suppression

12.3.6. Anxiety

12.3.7. Seizure

12.3.8. Others

12.4. Market Value Forecast, by Distribution Channel, 2017-2027

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online Pharmacies

12.5. Market Value Forecast, by Country/Sub-region, 2017-2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Market Attractiveness Analysis

12.6.1. By Drug

12.6.2. By Application

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America Controlled Substance Market Analysis and Forecast, 2017-2027

13.1. Introduction

13.1.1. Key Finding

13.2. Market Value Forecast, by Drug, 2017-2027

13.2.1. Opioids

13.2.1.1. Codeine

13.2.1.2. Morphine

13.2.1.3. Fentanyl

13.2.1.4. Hydrocodone

13.2.1.5. Tramadol

13.2.1.6. Oxycodone

13.2.1.7. Others

13.2.2. Stimulants

13.2.2.1. Amphetamine

13.2.2.2. Methylphenidate

13.2.2.3. Dextroamphetamine

13.2.2.4. Methamphetamine

13.2.2.5. Modafinil

13.2.2.6. Others

13.2.3. Depressants

13.2.3.1. Barbiturates

13.2.3.2. Benzodiazepines

13.2.4. Cannabinoids

13.3. Market Value Forecast, by Application, 2017-2027

13.3.1. ADHD

13.3.2. Pain Management

13.3.3. Depression

13.3.4. Sleep Disorder

13.3.5. Cough Suppression

13.3.6. Anxiety

13.3.7. Seizure

13.3.8. Others

13.4. Market Value Forecast, by Distribution Channel, 2017-2027

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Online Pharmacies

13.5. Market Value Forecast by Country/Sub-region, 2017-2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Market Attractiveness Analysis

13.6.1. By Drug

13.6.2. By Application

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region


14. Middle East & Africa Controlled Substance Market Analysis and Forecast, 2017-2027

14.1. Introduction

14.1.1. Key Finding

14.2. Market Value Forecast, by Drug, 2017-2027

14.2.1. Opioids

14.2.1.1. Codeine

14.2.1.2. Morphine

14.2.1.3. Fentanyl

14.2.1.4. Hydrocodone

14.2.1.5. Tramadol

14.2.1.6. Oxycodone

14.2.1.7. Others

14.2.2. Stimulants

14.2.2.1. Amphetamine

14.2.2.2. Methylphenidate

14.2.2.3. Dextroamphetamine

14.2.2.4. Methamphetamine

14.2.2.5. Modafinil

14.2.2.6. Others

14.2.3. Depressants

14.2.3.1. Barbiturates

14.2.3.2. Benzodiazepines

14.2.4. Cannabinoids

14.3. Market Value Forecast, by Application, 2017-2027

14.3.1. ADHD

14.3.2. Pain Management

14.3.3. Depression

14.3.4. Sleep Disorder

14.3.5. Cough Suppression

14.3.6. Anxiety

14.3.7. Seizure

14.3.8. Others

14.4. Market Value Forecast, by Distribution Channel, 2017-2027

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Market Value Forecast, by Country/Sub-region, 2017-2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Market Attractiveness Analysis

14.6.1. By Drug

14.6.2. By Application

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region


15. Competition Landscape

15.1. Market Player – Competition Matrix (By Tier and Size of companies)

15.2. Market Position/Ranking Analysis by Company (2018)

15.3. Company Profiles

15.3.1. F. Hoffmann-La Roche AG

15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.1.2. Company Financials

15.3.1.3. Growth Strategies

15.3.1.4. SWOT Analysis

15.3.2. AbbVie, Inc.

15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.2.2. Company Financials

15.3.2.3. Growth Strategies

15.3.2.4. SWOT Analysis

15.3.3. Mallinckrodt plc

15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.3.2. Company Financials

15.3.3.3. Growth Strategies

15.3.3.4. SWOT Analysis

15.3.4. Pfizer, Inc.

15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.4.2. Company Financials

15.3.4.3. Growth Strategies

15.3.4.4. SWOT Analysis

15.3.5. Sun Pharmaceutical Ltd.

15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.5.2. Company Financials

15.3.5.3. Growth Strategies

15.3.5.4. SWOT Analysis

15.3.6. Ampac Fine Chemicals

15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.6.2. Company Financials

15.3.6.3. Growth Strategies

15.3.6.4. SWOT Analysis

15.3.7. GW Pharmaceuticals plc

15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.7.2. Company Financials

15.3.7.3. Growth Strategies

15.3.7.4. SWOT Analysis

15.3.8. Merck & Co., Inc.

15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.8.2. Company Financials

15.3.8.3. Growth Strategies

16.3.8.4. SWOT Analysis



List of Figures



Figure 01: Global Controlled Substance Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Market Opportunity Map, by Drug Type, 2018

Figure 03: Global Controlled Substance Market Value (US$ Mn) Forecast, 2017–2027

Figure 04: Global Controlled Substance Market Value Share, by Drug (2018)

Figure 05: Global Controlled Substance Market Value Share, by Application (2018)

Figure 06: Global Controlled Substance Market Value Share, by Distribution Channels (2018)

Figure 07: Global Controlled Substance Market Value Share, by Region (2018)

Figure 08: Global Controlled Substance Market Value Share Analysis, by Drug, 2018 and 2027

Figure 09: Global Controlled Substance Market Revenue (US$ Mn) by Opioids, 2017-2027

Figure 10: Global Controlled Substance Market Revenue (US$ Mn) by Stimulants, 2017-2027

Figure 11: Global Controlled Substance Market Revenue (US$ Mn) by Depressants, 2017-2027

Figure 12: Global Controlled Substance Market Revenue (US$ Mn) by Cannabinoids, 2017-2027

Figure 13: Global Controlled Substance Market Attractiveness Analysis, by Drug, 2019–2027

Figure 14: Global Controlled Substance Market Value Share Analysis, by Application, 2018 and 2027

Figure 15: Global Controlled Substance Market Value (US$ Mn), by ADHD, 2017–2027

Figure 16: Global Controlled Substance Market Value (US$ Mn), by Pain Management, 2017–2027

Figure 17: Global Controlled Substance Market Value (US$ Mn), by Depression, 2017–2027

Figure 18: Global Controlled Substance Market Value (US$ Mn), by Sleep Disorder, 2017–2027

Figure 19: Global Controlled Substance Market Value (US$ Mn), by Cough Suppression, 2017–2027

Figure 20: Global Controlled Substance Market Value (US$ Mn), by Anxiety, 2017–2027

Figure 21: Global Controlled Substance Market Value (US$ Mn), by Seizure, 2017–2027

Figure 22: Global Controlled Substance Market Value (US$ Mn), by Others, 2017–2027

Figure 23: Global Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 24: Global Controlled Substance Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 25: Global Controlled Substance Market Revenue (US$ Mn) by Hospital Pharmacies, 2017-2027

Figure 26: Global Controlled Substance Market Revenue (US$ Mn) Retail Pharmacies, 2017-2027

Figure 27: Global Controlled Substance Market Revenue (US$ Mn) Online Pharmacies, 2017-2027

Figure 28: Global Controlled Substance Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 29: Global Controlled Substance Market Value Share Analysis, by Region, 2018 and 2027

Figure 30: Global Controlled Substance Market Attractiveness Analysis, by Region, 2019–2027

Figure 31: North America Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 32: North America Controlled Substance Market Value Share, by Country, 2018 and 2027

Figure 33: North America Controlled Substance Market Attractiveness, by Country, 2019–2027

Figure 34: North America Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 35: North America Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 36: North America Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 37: North America Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 38: North America Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 39: North America Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 40: Europe Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 41: Europe Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 42: Europe Controlled Substance Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 43: Europe Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 44: Europe Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 45: Europe Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 46: Europe Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 47: Europe Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 48: Europe Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 49: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 50: Asia Pacific Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 51: Asia Pacific Controlled Substance Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 52: Asia Pacific Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 53: Asia Pacific Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 54: Asia Pacific Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 55: Asia Pacific Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 56: Asia Pacific Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 57: Asia Pacific Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 58: Latin America Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 59: Latin America Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 60: Latin America Controlled Substance Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 61: Latin America Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 62: Latin America Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 63: Latin America Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 64: Latin America Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 65: Latin America Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 66: Latin America Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 67: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 68: Middle East & Africa Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 69: Middle East & Africa Controlled Substance Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 70: Middle East & Africa Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 71: Middle East & Africa Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 72: Middle East & Africa Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 73: Middle East & Africa Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 74: Middle East & Africa Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 75: Middle East & Africa Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 76: Market Position/Ranking Analysis, 2018, by Tier and Size of the Company


List of Tables



Table 01: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 02: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 03: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 04: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 05: Global Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 06: Global Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 07: Global Controlled Substance Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 08: North America Controlled Substance Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 10: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 11: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 12: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 13: North America Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 14: North America Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 17: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 18: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 19: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 20: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 21: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 22: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 23: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 24: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 25: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 26: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 27: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 28: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 29: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 31: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 32: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 33: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 34: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 35: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 36: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 37: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 38: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 39: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 40: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 41: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 42: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027